Search research articles
Contact Us
Filters
Showing results (841-850 of 851) with videos related to
Page
of 86
Sort By:
Cellular and Molecular Gastroenterology and Hepatology
|
January 31, 2026
Pcdh20 is a POU2F3 target gene required for proper tuft cell microvillus organization
Katherine E Ankenbauer, Yilin Yang, Chi-Yeh Chung, et al.
Nature
|
February 9, 2017
Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity
Kristen M Turner, Viraj Deshpande, Doruk Beyter, et al.
Pharmacoepidemiology and Drug Safety
|
July 19, 2012
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination
Priscilla Velentgas, Anthony A Amato, Rhonda L Bohn, et al.
Nature Communications
|
February 23, 2016
Establishment of human iPSC-based models for the study and targeting of glioma initiating cells
Ignacio Sancho-Martinez, Emmanuel Nivet, Yun Xia, et al.
The Journal of Infectious Diseases
|
November 24, 1999
Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine
S Frey, R Dagan, Y Ashur, et al.
Gastroenterology
|
October 25, 2021
Single-Cell Transcriptomics Reveals a Conserved Metaplasia Program in Pancreatic Injury
Zhibo Ma, Nikki K Lytle, Bob Chen, et al.
Gastroenterology
|
July 28, 2020
Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D<sub>2</sub>
Kathleen E DelGiorno, Chi-Yeh Chung, Vera Vavinskaya, et al.
Cell
|
September 27, 2014
Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy
Mara H Sherman, Ruth T Yu, Dannielle D Engle, et al.
Science (New York, N.Y.)
|
April 4, 2020
Cysteine depletion induces pancreatic tumor ferroptosis in mice
Michael A Badgley, Daniel M Kremer, H Carlo Maurer, et al.
Nature
|
April 19, 2019
Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring
Yu Shi, Weina Gao, Nikki K Lytle, et al.
Page
of 86
Search research articles
Search
Showing results (841-850 of 851) with videos related to
Sort By:
Page
of 86
Cellular and Molecular Gastroenterology and Hepatology
|
January 31, 2026
Pcdh20 is a POU2F3 target gene required for proper tuft cell microvillus organization
Katherine E Ankenbauer, Yilin Yang, Chi-Yeh Chung, et al.
Nature
|
February 9, 2017
Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity
Kristen M Turner, Viraj Deshpande, Doruk Beyter, et al.
Pharmacoepidemiology and Drug Safety
|
July 19, 2012
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination
Priscilla Velentgas, Anthony A Amato, Rhonda L Bohn, et al.
Nature Communications
|
February 23, 2016
Establishment of human iPSC-based models for the study and targeting of glioma initiating cells
Ignacio Sancho-Martinez, Emmanuel Nivet, Yun Xia, et al.
The Journal of Infectious Diseases
|
November 24, 1999
Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine
S Frey, R Dagan, Y Ashur, et al.
Gastroenterology
|
October 25, 2021
Single-Cell Transcriptomics Reveals a Conserved Metaplasia Program in Pancreatic Injury
Zhibo Ma, Nikki K Lytle, Bob Chen, et al.
Gastroenterology
|
July 28, 2020
Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D<sub>2</sub>
Kathleen E DelGiorno, Chi-Yeh Chung, Vera Vavinskaya, et al.
Cell
|
September 27, 2014
Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy
Mara H Sherman, Ruth T Yu, Dannielle D Engle, et al.
Science (New York, N.Y.)
|
April 4, 2020
Cysteine depletion induces pancreatic tumor ferroptosis in mice
Michael A Badgley, Daniel M Kremer, H Carlo Maurer, et al.
Nature
|
April 19, 2019
Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring
Yu Shi, Weina Gao, Nikki K Lytle, et al.
Page
of 86